论文部分内容阅读
本文对合并应用地戈辛30例慢性充血性心衰住院患者进行了血药浓度的监测,报道如下:资料与方法30例中男性23例,女性7例。年龄46～82岁,平均62.6岁。风湿性心脏病6例,冠心病3例、肺心病21例。30例随机分为5组:单用地戈辛6例(Ⅰ组),地戈辛十安体舒通6例(Ⅱ组),地戈辛+心痛定6例(Ⅲ组),地戈辛十抗生素(四环素、红霉素)6例(Ⅳ组)。地戈辛十胃复安6例(Ⅴ组)。30例病人检查尿常规、尿素氮、肌酐及肝功能均在正常范围。在监测期均不合用其它药物治疗。
In this paper, 30 cases of geoxin combined with chronic congestive heart failure inpatients were monitored blood concentration, reported as follows: Materials and Methods 30 cases of male 23, female 7. Age 46 to 82 years old, average 62.6 years old. 6 cases of rheumatic heart disease, 3 cases of coronary heart disease, 21 cases of pulmonary heart disease. 30 patients were randomly divided into 5 groups: digoxin alone in 6 cases (group Ⅰ), geothin ten diacetate in 6 cases (group Ⅱ), digoxin + xintong in 6 cases (group Ⅲ) Ten antibiotics (tetracycline, erythromycin) in 6 cases (group Ⅳ). Geoxein ten stomach Fufang 6 cases (Ⅴ group). Thirty patients were examined for urinalysis, urea nitrogen, creatinine and liver function in the normal range. During the monitoring period are not combined with other drug treatment.